The Claim

In lysosomes isolated from KKAy mice with hepatic steatosis, the expression of V-ATPase subunits ATP6v1a, ATP6v1b, and ATP6v1d is reduced at both the RNA and protein levels, indicating a potential decrease in lysosomal acidification capacity in the context of fatty liver disease.

Source: Inhibition of mTOR improves the impairment of acidification in autophagic vesicles caused by hepatic steatosis.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
10score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In mice with fatty liver, certain proteins and their genetic instructions are lower in the liver's waste-processing units, which might mean those units aren't working as well as they should.

See the scientific wording

Expression of V-ATPase subunits ATP6v1a, ATP6v1b, and ATP6v1d is suppressed at both protein and RNA levels in lysosomes isolated from KKAy mice with hepatic steatosis, suggesting reduced lysosomal acidification capacity in fatty liver disease.

What the research says

1 study

  1. Study: Inhibition of mTOR improves the impairment of acidification in autophagic vesicles caused by hepatic steatosis.

    The study found that in mice with fatty livers, the proteins and genes needed to make lysosomes acidic were lower, which matches the claim.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.